Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$21.64
Market cap
$876.5M
P/E Ratio
50.33
Dividend/share
$0.48
EPS
$0.43
Enterprise value
$1.3B
Phibro Animal Health Corporation is a diversified global developer, manufacturer and supplier of a broad range of animal health and mineral nutrition products for livestock, helping veterinarians and farmers produce
Highlights
PAHC's gross profit is up by 11% year-on-year and by 5% since the previous quarter
The revenue has increased by 7% year-on-year and by 2.9% since the previous quarter
PAHC's P/E is 50% below its last 4 quarters average of 100.6 but 40% above its 5-year quarterly average of 36.0
PAHC's EPS is down by 17% year-on-year
PAHC's net income is down by 16% year-on-year
Key stats
What are the main financial stats of PAHC
Market
Valuations
Earnings
Shares outstanding
40.5M
Market cap
$876.5M
Enterprise value
$1.3B
Price to earnings (P/E)
50.33
Price to book (P/B)
3.39
Price to sales (P/S)
0.84
EV/EBIT
24
EV/EBITDA
14.36
EV/Sales
1.24
Revenue
$1.05B
Gross profit
$328.86M
Net income
$17.41M
EBIT
$54.13M
EBITDA
$90.44M
Free cash flow
$40.67M
Per share
Balance sheet
Liquidity
EPS
$0.43
EPS diluted
$0.43
Free cash flow per share
$1
Book value per share
$6.38
Revenue per share
$25.84
TBVPS
$21.45
Total assets
$966.29M
Total liabilities
$707.76M
Debt
$474.17M
Equity
$258.53M
Working capital
$393.87M
Debt to equity
1.83
Current ratio
3.23
Quick ratio
1.42
Net debt/EBITDA
4.67
Margins
Efficiency
Dividend
EBITDA margin
8.6%
Gross margin
31.4%
Net margin
1.7%
Operating margin
6.9%
Return on assets
1.8%
Return on equity
6.6%
Return on invested capital
4.9%
Return on capital employed
6.9%
Return on sales
5.2%
Dividend yield
2.22%
DPS
$0.48
Payout ratio
111.6%
PAHC stock price
How has the Phibro Animal Health stock price performed over time
Intraday
0%
1 week
-3.13%
1 month
-8.85%
1 year
93.04%
YTD
86.87%
QTD
-3.91%
Financial performance
How have Phibro Animal Health's revenue and profit performed over time
Revenue
$1.05B
Gross profit
$328.86M
Operating income
$71.74M
Net income
$17.41M
Gross margin
31.4%
Net margin
1.7%
PAHC's operating income is up by 35% since the previous quarter and by 25% year-on-year
The operating margin rose by 33% since the previous quarter and by 17% year-on-year
PAHC's net margin is down by 19% YoY
PAHC's net income is down by 16% year-on-year
Growth
What is Phibro Animal Health's growth rate over time
Valuation
What is Phibro Animal Health stock price valuation
P/E
50.33
P/B
3.39
P/S
0.84
EV/EBIT
24
EV/EBITDA
14.36
EV/Sales
1.24
PAHC's P/E is 50% below its last 4 quarters average of 100.6 but 40% above its 5-year quarterly average of 36.0
PAHC's EPS is down by 17% year-on-year
PAHC's P/B is 36% above its last 4 quarters average of 2.5 and 2.7% above its 5-year quarterly average of 3.3
The equity is down by 5% year-on-year
The stock's price to sales (P/S) is 40% more than its last 4 quarters average of 0.6 but 7% less than its 5-year quarterly average of 0.9
The revenue has increased by 7% year-on-year and by 2.9% since the previous quarter
Efficiency
How efficient is Phibro Animal Health business performance
The ROIC has soared by 88% from the previous quarter and by 2.1% YoY
PAHC's return on sales has surged by 79% since the previous quarter but it is down by 5% year-on-year
Phibro Animal Health's ROA has decreased by 14% YoY
The return on equity has declined by 13% year-on-year
Dividends
What is PAHC's dividend history
DPS
$0.48
Dividend yield
2.22%
Payout ratio
111.6%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Phibro Animal Health financials performed over time
Phibro Animal Health's total assets is 37% higher than its total liabilities
Phibro Animal Health's current ratio has increased by 10% QoQ but it has decreased by 4.7% YoY
The quick ratio has increased by 2.2% from the previous quarter and by 2.2% YoY
PAHC's debt is 83% higher than its equity
The equity is down by 5% year-on-year
PAHC's debt to equity is down by 3.7% from the previous quarter but it is up by 3.4% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.